Medline Inc. IPO - What You Need to Know

Thinking about jumping into the Medline IPO? It is a massive name in the medical world. Now that the official paperwork is out, we have the hard numbers. Here is the breakdown in plain English.

1. What does this company actually do?

Think of Medline as the "Amazon of the hospital world." They manage the entire supply chain for hospitals, nursing homes, and surgery centers.

• Medline Brand: They manufacture their own products, including surgical gowns, gloves, and diagnostic tools. They offer about 190,000 items. Roughly 65% of their revenue comes from products they make themselves.
• Supply Chain Solutions: They act as a logistics expert, helping hospitals manage inventory through data-driven systems.

With 70 distribution centers and 2,100 trucks, they deliver to 95% of U.S. customers by the next day. They are also expanding into at-home care kits for patients leaving the hospital.

2. The IPO Details

Medline trades on the Nasdaq under the ticker symbol "MDLN."

• The Price: Shares cost $41.00 each.
• The Offering: The company sold 75 million shares.
• Important Note: This was a "secondary" offering. Medline received no cash from this sale. Instead, the current owners—the Mills family and private equity firms like Blackstone, Carlyle, and Hellman & Friedman—sold a portion of their own shares.

3. How do they make money?

In 2025, Medline generated $28.4 billion in revenue and $1.2 billion in profit.

They use a "Prime Vendor" model. They sign 5-year contracts to serve as the main supplier for healthcare systems. This creates a "flywheel effect":

• The Conversion Strategy: Once they become the primary vendor, Medline encourages hospitals to switch from name-brand items to Medline’s own products. These private-label goods carry higher profit margins.
• Retention: Their model is very sticky. They kept 98% of their customers over the last five years.

4. The "Complex" Ownership Structure

Medline uses an "UP-C" structure, which creates a dual-tier tax and equity arrangement.

• The Insiders: The Mills family and private equity partners hold "Units" in a partnership that owns the business.
• The Public: As an IPO investor, you hold "Class A" stock in a corporation that owns a small piece of that partnership.
• Why it matters: This setup gives original owners tax benefits. Furthermore, the insiders keep significant voting control through high-vote shares. They control board appointments and major decisions, regardless of how many shares the public owns.

5. What are the main risks?

• Debt: The company carries a heavy debt load. Interest payments eat up cash that could fund growth, and rising interest rates make this debt more expensive.
• Control: Because insiders hold most of the voting power, public shareholders have little say in how the company is run.
• Margin Compression: Hospitals are merging into larger systems. These groups have more power to demand lower prices, which could shrink Medline’s profit margins.
• Regulatory Risk: Changes in government payments for hospitals, like Medicare or Medicaid, can lower the demand for Medline’s supplies.

6. A Final Reality Check

Before you buy, remember that IPOs are volatile. The stock price will likely swing based on contract renewals and healthcare spending trends.

Pro Tip: If you are serious about investing, read the "Risk Factors" section of their official filing. It details legal risks and supply chain issues that could threaten their 98% customer retention rate. Always look at how much of their debt is tied to variable interest rates—that will be a major indicator of their future cash flow health.

Disclaimer: I am an AI, not a financial advisor. Investing in IPOs carries risk. Always do your own research or talk to a professional before investing.